Dr. Anthony Ng, MD

NPI: 1649202367
Total Payments
$21,362
2024 Payments
$2,158
Companies
37
Transactions
804
Medicare Patients
2,276
Medicare Billing
$380,174

Payment Breakdown by Category

Food & Beverage$17,930 (83.9%)
Other$2,792 (13.1%)
Consulting$600.00 (2.8%)
Education$39.98 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,930 799 83.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,792 2 13.1%
Consulting Fee $600.00 1 2.8%
Education $39.98 2 0.2%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $4,337 162 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $3,956 235 $0 (2024)
ABBVIE INC. $2,809 90 $0 (2024)
RedHill Biopharma Inc. $2,534 27 $0 (2024)
FUJIFILM Medical Systems USA, Inc. $1,292 1 $0 (2017)
IRONWOOD PHARMACEUTICALS, INC $940.60 49 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $611.53 29 $0 (2022)
INTERCEPT PHARMACEUTICALS, INC. $562.15 24 $0 (2023)
Concordia Pharmaceuticals Inc. $476.77 22 $0 (2019)
Allergan Inc. $456.79 21 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,158 109 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($629.86)
2023 $2,287 107 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($575.52)
2022 $2,013 104 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($754.01)
2021 $2,610 121 Gilead Sciences, Inc. ($665.47)
2020 $3,514 79 RedHill Biopharma Inc. ($2,185)
2019 $3,343 112 Gilead Sciences, Inc. ($845.85)
2018 $2,276 91 Gilead Sciences, Inc. ($678.02)
2017 $3,161 81 FUJIFILM Medical Systems USA, Inc. ($1,292)

All Payment Transactions

804 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
12/20/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.82 General
12/19/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $19.41 General
Category: LIVER DISEASE
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.84 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.56 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $1.84 General
Category: Gastroenterology
12/17/2024 VIVUS LLC PANCREAZE (Drug) Food and Beverage In-kind items and services $18.42 General
Category: GASTROENTEROLOGY
12/16/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $21.84 General
Category: GI
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.23 General
Category: Gastroenterology
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $1.32 General
Category: Gastroenterology
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.34 General
Category: Gastroenterology
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.16 General
Category: Gastroenterology
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.78 General
Category: Gastroenterology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.95 General
Category: Gastroenterology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Gastroenterology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $3.19 General
Category: Gastroenterology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $1.46 General
Category: Gastroenterology
11/19/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $7.46 General
11/12/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $19.41 General
Category: GI
11/08/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $29.13 General
11/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.58 General
Category: Gastroenterology
11/06/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $19.99 General
Category: LIVER DISEASE
11/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $0.65 General
Category: Gastroenterology
10/29/2024 VIVUS LLC PANCREAZE (Drug) Food and Beverage In-kind items and services $18.41 General
Category: GASTROENTEROLOGY
10/28/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $18.95 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $34.59 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 494 605 $142,185 $77,883
2022 10 567 657 $192,954 $98,066
2021 12 684 861 $206,825 $121,473
2020 7 531 697 $169,124 $82,753
Total Patients
2,276
Total Services
2,820
Medicare Billing
$380,174
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 144 224 $32,908 $17,398 52.9%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Office 2023 45 45 $26,864 $15,520 57.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 96 118 $24,773 $13,267 53.6%
45380 Biopsy of large bowel using a flexible endoscope Office 2023 36 36 $18,638 $10,164 54.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 56 56 $14,224 $8,028 56.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Office 2023 16 16 $10,372 $6,740 65.0%
76981 Ultrasound scan of organ tissue for measuring elasticity Office 2023 18 20 $3,244 $1,948 60.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 24 24 $6,000 $1,876 31.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 28 31 $3,192 $1,521 47.7%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 31 35 $1,970 $1,419 72.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Office 2022 65 67 $41,577 $24,877 59.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 131 154 $41,397 $17,987 43.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 148 205 $39,756 $15,807 39.8%
45380 Biopsy of large bowel using a flexible endoscope Office 2022 38 38 $19,155 $11,071 57.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Office 2022 23 23 $15,691 $10,172 64.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 44 44 $11,400 $6,920 60.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Office 2022 16 16 $10,178 $5,009 49.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 31 31 $7,750 $2,844 36.7%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2022 57 65 $4,160 $2,636 63.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 14 14 $1,890 $742.75 39.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 181 240 $48,300 $29,084 60.2%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Office 2021 71 73 $42,676 $27,851 65.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 173 272 $44,179 $23,276 52.7%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Office 2021 23 24 $16,448 $11,094 67.4%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Office 2021 37 37 $18,720 $10,963 58.6%

About Dr. Anthony Ng, MD

Dr. Anthony Ng, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649202367.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Ng, MD has received a total of $21,362 in payments from pharmaceutical and medical device companies, with $2,158 received in 2024. These payments were reported across 804 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($17,930).

As a Medicare-enrolled provider, Ng has provided services to 2,276 Medicare beneficiaries, totaling 2,820 services with total Medicare billing of $380,174. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location New York, NY
  • Active Since 07/06/2006
  • Last Updated 11/17/2022
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1649202367

Products in Payments

  • XIFAXAN (Drug) $2,950
  • Talicia (Drug) $1,916
  • ESD - Core Endoscopy (Device) $1,292
  • Creon (Drug) $1,067
  • LINZESS (Drug) $946.14
  • TRULANCE (Drug) $875.96
  • Linzess (Drug) $589.46
  • CREON (Drug) $577.68
  • ZENPEP (Drug) $500.63
  • VIBERZI (Drug) $463.74
  • DIFICID (Drug) $426.25
  • OCALIVA (Drug) $376.19
  • Amitiza (Drug) $356.28
  • PANCREAZE (Drug) $323.39
  • Donnatal (Drug) $291.82
  • Vemlidy (Drug) $275.62
  • XELJANZ (Drug) $250.39
  • MOTEGRITY (Drug) $238.28
  • Epclusa (Drug) $224.99
  • CONTRAVE (Drug) $190.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in New York